Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Cough; cold symptoms; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of cough in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. In DEC-2024, the patient received RSV vaccine. On 27-JAN-2025, between 1 and 2 months after receiving RSV vaccine, the patient experienced cough (Verbatim: Cough) and cold symptoms (Verbatim: cold symptoms). The patient was treated with prednisone. The outcome of the cough and cold symptoms were resolving. It was unknown if the reporter considered the cough and cold symptoms to be related to RSV vaccine. It was unknown if the company considered the cough and cold symptoms to be related to RSV vaccine. Additional Information: GSK Receipt Date: 24-FEB-2025 This case was reported by a patient via interactive digital media. The patient had the RSV shot in December. On January 27th, he/she had a terrible cough and cold symptoms. The patient had scheduled appointment with his/her physician on that day. The physician prescribed antibiotics and something for the cough. One week in and patient was still sick, so the physician sent him/her a prednisone pack. Three weeks later the patient was just getting better. The patient was thanking his/her physician. The patient further stated, he/she could not remember when he/she was that sick.